Recombinant multi-species CBFB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CBFB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is the beta subunit of a heterodimeric core-binding transcription factor belonging to the PEBP2/CBF transcription factor family which master-regulates a host of genes specific to hematopoiesis (e.g., RUNX1) and osteogenesis (e.g., RUNX2). The beta subunit is a non-DNA binding regulatory subunit; it allosterically enhances DNA binding by alpha subunit as the complex binds to the core site of various enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers and GM-CSF promoters. Alternative splicing generates two mRNA variants, each encoding a distinct carboxyl terminus. In some cases, a pericentric inversion of chromosome 16 [inv(16)(p13q22)] produces a chimeric transcript consisting of the N terminus of core-binding factor beta in a fusion with the C-terminal portion of the smooth muscle myosin heavy chain 11. This chromosomal rearrangement is associated with acute myeloid leukemia of the M4Eo subtype. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CBF-beta,CBFB,CBFb-2,CLCD2,Cbfb,Core-binding factor subunit beta,PEA2,PEBP2-beta),PEBP2B,PEBP2b,Pebp2,Pebpb2,Polyomavirus enhancer-binding protein 2 beta subunit (PEA2-beta,SL3-3 enhancer factor 1 subunit beta,SL3/AKV core-binding factor beta subunit
Go
to CBFB products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13229-Ag-1/ GM-Tg-hg-IP13229-Ag-2 | Human CBFB protein | Human |
| GM-Tg-rg-IP13229-Ag-1/ GM-Tg-rg-IP13229-Ag-2 | Rat CBFB protein | Rat |
| GM-Tg-mg-IP13229-Ag-1/ GM-Tg-mg-IP13229-Ag-2 | Mouse CBFB protein | Mouse |
| GM-Tg-cynog-IP13229-Ag-1/ GM-Tg-cynog-IP13229-Ag-2 | Cynomolgus/Rhesus macaque CBFB protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13229-Ag-1/ GM-Tg-felg-IP13229-Ag-2 | Feline CBFB protein | Feline |
| GM-Tg-cang-IP13229-Ag-1/ GM-Tg-cang-IP13229-Ag-2 | Canine CBFB protein | Canine |
| GM-Tg-bovg-IP13229-Ag-1/ GM-Tg-bovg-IP13229-Ag-2 | Bovine CBFB protein | Bovine |
| GM-Tg-equg-IP13229-Ag-1/ GM-Tg-equg-IP13229-Ag-2 | Equine CBFB protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13229-Ag-1/ GM-Tg-hg-IP13229-Ag-2;
GM-Tg-rg-IP13229-Ag-1/ GM-Tg-rg-IP13229-Ag-2;
GM-Tg-mg-IP13229-Ag-1/ GM-Tg-mg-IP13229-Ag-2; GM-Tg-cynog-IP13229-Ag-1/ GM-Tg-cynog-IP13229-Ag-2; GM-Tg-felg-IP13229-Ag-1/ GM-Tg-felg-IP13229-Ag-2; GM-Tg-cang-IP13229-Ag-1/ GM-Tg-cang-IP13229-Ag-2; GM-Tg-bovg-IP13229-Ag-1/ GM-Tg-bovg-IP13229-Ag-2; GM-Tg-equg-IP13229-Ag-1/ GM-Tg-equg-IP13229-Ag-2 |
| Products Name | CBFB protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CBFB |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CBFB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.